Breaking News: Parkinson’s Vaccine Study Shows Promising Results

Parkinson's Disease | Vaccine for Parkinson's Reports Positive Results from Boost Study

Vaccine Against Key Parkinson's Target Reports Positive Booster Study Results

New study results support the continued development of a vaccine against the key Parkinson's protein alpha-synuclein. Researchers hope this therapy may slow or stop disease progression.

The "booster" follow-up study, led by Austrian biotech AFFiRiS and funded by The Michael J. Fox Foundation, built on a positive Phase I clinical trial and allowed researchers to learn more about the potential application of this vaccine and its safety. https://www.michaeljfox.org/foundation/news-detail.php?vaccine-for-parkinson-reports-positive-results-from-boost-study&et_cid=663718&et_rid=110264462&et_lid=https%253a%252f%252fwww.michaeljfox.org%252ffoundation%252fnews-detail.php%253fvaccine-for-parkinson-reports-positive-results-from-boost-studyem_cid= The Michael J. Fox Foundation Grand Central Station, P.O. Box 4777 New York, NY 10163-4777 1-800-708-7644